Second, Li et al. demonstrated that metformin treatment in diabetic patients with ovarian cancer was associated with reduced circulating MDSCs, a concomitant increase in the circulating CD8+ T cells, and longer survival [29]. Here, CD8A is linked to ovarian cancer.